Article

High-Throughput Global Phosphoproteomic Profiling Using Phospho Heavy-Labeled-Spiketide FAIMS Stepped-CV DDA (pHASED)

2022-04-22

Abstract excerpt

<h4>ABSTRACT</h4> Global high-throughput profiling of oncogenic signaling pathways by phosphoproteomics is increasingly being applied to cancer specimens. Such quantitative unbiased phosphoproteomic profiling of cancer cells identifies oncogenic signaling cascades that drive disease initiation and progression; pathways that are often invisible to genomics sequencing strategies. Therefore, phosphoproteomic profili...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 45b689c0-9787-5a3f-8c94-1b38773ab15b
DOI: 10.1101/2022.04.22.489124

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High-Throughput Global Phosphoproteomic Profiling Using Phospho Heavy-Labeled-Spiketide FAIMS Stepped-CV DDA (pHASED)DOI 10.1101/2022.04.22.489124Read

Phospho heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selectionSemantic proximity Read

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.Semantic proximity Read

Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AMLSemantic proximity Read

TOPAS: phosphoproteome data analysis and decision support platform for molecular tumor boardsSemantic proximity Read

Utilizing proteomics and phosphoproteomics to predict <i>ex vivo</i> drug sensitivity across genetically diverse AML patientsSemantic proximity Read

Proteomics and Phosphoprotoemic Measurements Enhance Ability to Predict Ex Vivo Drug Response in AMLSemantic proximity Read

Phosphotyrosine-based Phosphoproteomics for Target Identification and Drug Response Prediction in AML Cell Lines.Semantic proximity Read

Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategiesSemantic proximity Read

Mining the tumor phosphoproteome for cancer markers.Semantic proximity Read

Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemiaSemantic proximity Read

Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncologySemantic proximity Read

Multiplexed phosphoproteomics of low cell numbers using SPARCESemantic proximity Read